PARP1 and cancer: Tan and his colleagues, for the first time, reported the immunogenic and autoantibodies to PARP1 in human sera and the presence of autoantibodies to PARP1were in the sera from cancer patients with Paraneoplastic Neurologic Syndrome [9].